Table 1 Univariate analysis of prostate PSM
Characteristic | OR1 | 95% CI1 | p-value2 |
|---|---|---|---|
Age | 0.98 | 0.93, 1.05 | 0.617 |
Hypertension | |||
0 | — | — | |
1 | 0.90 | 0.39, 2.12 | 0.814 |
Diabetes | |||
0 | — | — | |
1 | 1.32 | 0.47, 3.72 | 0.595 |
Coronary heart disease | |||
0 | — | — | |
1 | 1.17 | 0.20, 6.76 | 0.859 |
BMI | |||
1 | — | — | |
2 | 1.68 | 0.54, 5.21 | 0.369 |
TPSA | |||
0 | — | — | |
1 | 2.28 | 0.97, 5.38 | 0.059 |
Prostate volume | |||
0 | — | — | |
1 | 10.83 | 3.87, 30.33 | < 0.001*** |
PIRADS | |||
3 | — | — | |
4 | 3.49 | 1.01, 12.03 | 0.048* |
5 | 6.34 | 1.79, 22.54 | 0.004** |
Extraprostatic extension | |||
0 | — | — | |
1 | 2.71 | 0.86, 8.53 | 0.089 |
The time between puncture and surgery | |||
0 | — | — | |
1 | 0.74 | 0.29, 1.91 | 0.534 |
Preoperative ISUP | |||
1 | — | — | |
2 | 1.71 | 0.48, 6.07 | 0.404 |
3 | 2.00 | 0.52, 7.76 | 0.316 |
4 | 2.18 | 0.60, 7.96 | 0.237 |
5 | 3.11 | 0.86, 11.29 | 0.084 |
The ratio of positive needle count | |||
0 | — | — | |
1 | 4.12 | 0.46, 36.67 | 0.204 |
2 | 6.24 | 0.75, 51.76 | 0.090 |
Preoperative endocrine therapy | |||
0 | — | — | |
1 | 1.92 | 0.60, 6.09 | 0.268 |
Operation time | 1.00 | 0.99, 1.01 | 0.995 |
Amount of bleeding | 0.99 | 0.99, 1.00 | 0.249 |
pT | |||
2 | — | — | |
3 | 8.71 | 3.04, 24.90 | < 0.001*** |
Postoperative ISUP | |||
1 | — | — | |
2 | 2.31 | 0.44, 12.20 | 0.325 |
3 | 3.60 | 0.59, 21.93 | 0.165 |
4 | 1.64 | 0.23, 11.70 | 0.624 |
5 | 4.62 | 0.84, 25.49 | 0.079 |
D’Amico | |||
2 | — | — | |
1 | 0.82 | 0.35, 1.92 | 0.645 |
Nerve invasion | |||
0 | — | — | |
1 | 2.60 | 0.89, 7.62 | 0.082 |
Vascular cancer thrombus | |||
0 | — | — | |
1 | 1.17 | 0.20, 6.76 | 0.859 |